Self-medication and safety

被引:4
作者
Tillement, Jean-Paul
Delaveau, Pierre
机构
来源
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE | 2007年 / 191卷 / 08期
关键词
self medication; consumer product safety; iatrogenic disease; product surveillance; postmarketing; drug monitoring;
D O I
10.1016/S0001-4079(19)32901-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Most drugs used for self-medication act on pain, diarrhea, constipation, gastric acid hypersecretion, or allergic diseases. They are generally well-tolerated, provided the recommended dose regimen is respected Most adverse effects result from misuse (wrong indication, overdose, interactions, etc.). Self-medication can also be harmful by masking an underlying disease. Most of these untoward effects are avoidable. Severe adverse effects requiring hospital admission are easy to identify, but some milder reactions may only be discovered by chance. We discuss how to improve the safety of self-medication, particularly by involving public health stakeholders such as general practitioners, pharmacists and pharmaceutical firms, both through personal contact with self-medication users and through the mass media.
引用
收藏
页码:1517 / 1526
页数:10
相关论文
共 12 条
  • [1] Adenot I., 2007, Annales Pharmaceutiques Francaises, V65, P325, DOI 10.1016/S0003-4509(07)92595-X
  • [2] COULOMB A, 2007, AUTOMEDICATION FEV
  • [3] FONDOULIS D, 2002, RAPPORT GROUPE TRAVE
  • [4] Imbs JL, 1999, THERAPIE, V54, P21
  • [5] *LEEM, 2006, PREC UT INT DOM SANT
  • [6] *LNP, 2006, ACH MED TOIL APP PRU
  • [7] POUILLARD J, 2001, AUTOMEDICATION FEV
  • [8] QUENEAU P, 1992, B ACAD NAT MED PARIS, V176, P511
  • [9] QUENEAU P, 1998, RAPPORT MISSION IATR
  • [10] ROYER RJ, 2000, CLIN PHARM